Spotlight On... Novartis' troubled Alcon unit recalls eye drops for sterility, potency problems; Endo tanks on women's health sale; AZ sells rights to constipation drug; Denmark vies for EMA; and more...
Alcon becomes a separately traded standalone company | Novartis
Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3T4T5OVXSBPCFG3X5KLSKUSBI4.jpg "ALCC.S - | Stock Price & Latest News | Reuters")
ALCC.S - | Stock Price & Latest News | Reuters
Alcon CEO And Leadership: Executives and Demographics - Zippia
Alcon - Governance - Board of Directors
Thomas Glanzmann - Director at Alcon | The Org
Alcon becomes a separately traded standalone company | Novartis
Alcon - Governance - Board of Directors
Alcon Stock Forecast, price, news, analysis (ALC) | Strike.Market
Alcon - Governance - Board of Directors
Meet Our Board - Ophthalmology Foundation
PR%F the Magazine June 2022 by Food & Beverage Magazine - Issuu
Michael F. Land - Wikipedia
Michael Ball | LinkedIn
Michael Francis Land. 12 April 1942—14 December 2020 | Biographical Memoirs of Fellows of the Royal Society
Alcon Announces Results of 2023 Annual General Meeting
F. Michael Ball — CEO, Alcon at Novartis | Comparably
F. Michael Ball Net Worth (2023) | wallmine
Novartis sees weak Q4 and year, and expects a 2017 repeat, putting Alcon's future in question | Fierce Pharma
Alcon's top executive is out as eye-care sales plummet | Fort Worth Star-Telegram
F. Michael Ball News & Articles | Crain's Chicago Business
Mike Ball, Alcon Inc: Profile and Biography - Bloomberg Markets
Untitled
